Company Name:Illumina, Inc.
CEO: Francis A. deSouza

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.


Key numbers

Market Capitalization:56636160000
Shares Outstanding: 147000000
Float: 146387157
Next Earning Date:2020-08-06
TTm EPS: 6.4082
TTm Dividend Rate:
200 days moving average:317.69
50 days moving average: 367.24
One day percent Change: -0.16



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,